Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | BRAF | P15056 | 9/20 | 0.35 |
| ▸ | PIK3C3 | Q8NEB9 | 2/20 | 0.35 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.34 |
| ▸ | F10 | P00742 | 1/20 | 0.34 |
| ▸ | CALCA | P06881 | 1/20 | 0.33 |
| ▸ | CACNA1H | O95180 | 2/20 | 0.33 |
| ▸ | CACNA1C | Q13936 | 2/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14138580 | 0.84 | CACNA1H (0.43) | PKMBRAFCACNA1HCACNA1C | |
| SCHEMBL14138576 | 0.82 | HPGD (0.43) | PKMBRAFCACNA1HCACNA1C | |
| SCHEMBL3597417 | 0.81 | PKM (0.56) | PKMBRAF | |
| SCHEMBL14138535 | 0.77 | PRKCI (0.38) | PKMBRAF | |
| SCHEMBL14138705 | 0.75 | SCD (0.40) | BRAF | |
| SCHEMBL14138848 | 0.74 | CACNA1H (0.46) | CACNA1HCACNA1C | |
| SCHEMBL14138578 | 0.74 | CYP2C9 (0.41) | BRAFCACNA1HCACNA1C | |
| SCHEMBL14138603 | 0.73 | PKM (0.37) | PKMBRAF | |
| SCHEMBL3597415 | 0.73 | PKM (0.56) | PKMBRAF | |
| SCHEMBL14138708 | 0.73 | PKM (0.38) | PKMBRAF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008079277-A1 | CERTAIN PYRAZOLINE DERIVATIVES WITH KINASE INHIBITORY ACTIVITY | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2008-07-03 | — | — | WO | disclosed |